Lilly Eli & Co
- Pharmaceutical Preparations
- Indianapolis, Indiana
Compensation history
Top executives at Lilly Eli & Co received an average of $8M per person in annual compensation from 2006 to 2018.
Average pay of disclosed executives at Lilly Eli & Co
By year
- 2018
DR$17MDavid A. RicksChairman, President, and Chief Executive OfficerMH$5MMichael J. HarringtonSenior Vice President and General CounselJS$5MJeffrey N. SimmonsPresident, Chief Executive Officer and Director Elanco Animal Health, IncJS$5MJoshua L. SmileySenior Vice President and Chief Financial OfficerDS$5MDaniel M. SkovronskySenior Vice President and Chief Scientific OfficerEC$5MEnrique A. ConternoSenior Vice President and President, Lilly Diabetes and President, Lilly USA- 2016
JL$18MJohn C. LechleiterChairman, President, and Chief Executive OfficerDR$8MDerica W. RiceExecutive Vice President, Global Services, and Chief Financial OfficerJL$6MJan M. LundbergExecutive Vice President, Science and Technology, and President, Lilly Research LaboratoriesMH$5MMichael J. HarringtonSenior Vice President and General CounselEC$5MEnrique A. ConternoSenior Vice President and President, Lilly Diabetes
Executives
We found 15 executives who work or worked at Lilly Eli & Co.
David Ricks
Lilly Eli & Co
Chief Executive Officer
Joshua Smiley
Lilly Eli & Co
Chief Financial Officer
Michael Harrington
Lilly Eli & Co
General Counsel
Enrique Conterno
Lilly Eli & Co
Senior Vice President and President, Lilly Diabetes and President, Lilly USA
Daniel Skovronsky
Lilly Eli & Co
Chief Scientific Officer
Jeffrey Simmons
Lilly Eli & Co
Chief Executive Officer
John Lechleiter
Lilly Eli & Co
Chief Executive Officer
Derica Rice
Lilly Eli & Co
Chief Financial Officer
News
About Lilly Eli & Co
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- AddressLilly Corporate Ctr, Drop Code 1112, Indianapolis, Indiana 46285
- Phone3172762000
- Fiscal year endDecember 31
- Former names
- LILLY ELI & CO ET ALUntil October 13, 1994
Source: SEC filings on March 22, 2019, March 20, 2017, March 21, 2016, March 23, 2015, March 29, 2013, March 8, 2010, and March 5, 2007.